Results
Arrowhead Posts $5.11 Loss, Revenue Falls 46%
Arrowhead reported FY2026 loss of $5.11 per share versus consensus $3.51, and revenue of $450.8 million, missing $464.1 million estimate and down 46% YoY.
REDEMPLO prescriptions rose 63% QoQ, reaching
